Molecular Pharmacology (USA), Ltd. (MLPH)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 27, 2026
100.00%
Market Cap 199.91K
Revenue (ttm) n/a
Net Income (ttm) -105.18K
Shares Out 999.55M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,000
Average Volume 34,246
Open 0.0002
Previous Close n/a
Day's Range 0.0002 - 0.0002
52-Week Range 0.0000 - 0.0097
Beta 3.56
RSI 46.49
Earnings Date n/a

About MLPH

Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical di... [Read more]

Industry Shell Companies
Sector Financials
CEO Jeffrey Edwards
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MLPH
Full Company Profile

Financial Performance

News

There is no news available yet.